Compound ID | 610

Update compound information

Laspartomycin and analogues

Class: Lipopeptide

Spectrum of activity: Gram-negative
Institute where first reported: Biosource Pharma.; Intrabiotics Pharmaceuticals
Year first mentioned: 2001
Development status: Inactive
Chemical structure(s):
Click here for structure editor
Molecular weight: 1275.41
Iso. SMILES: CC[C@@H](C)[C@H]1C(=O)N2CCC[C@H]2C(=O)NC[C@@H](C(=O)N3CCCC[C@H]3C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NC(=O)CC(=O)N[C@H](C(=O)N1)[C@@H](C)O)CC(=O)O)CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)/C=C/CCCCCCCCCC(C)C
InChI Key: DSQHLPWCVYEPGM-GHJFOLTQSA-N
Can. SMILES: CC[C@@H](C)[C@H]1C(=O)N2CCC[C@H]2C(=O)NC[C@@H](C(=O)N3CCCC[C@H]3C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)NC(=O)CC(=O)N[C@@H]([C@@H](C)O)C(=O)N1)NC(=O)[C@H](CC(=O)O)NC(=O)/C=C/CCCCCCCCCC(C)C
InChI: InChI=1S/C58H90N12O20/c1-6-33(4)49-58(90)70-24-18-21-40(70)54(86)59-29-38(65-52(84)36(26-47(79)80)62-41(72)22-15-13-11-9-7-8-10-12-14-19-32(2)3)57(89)69-23-17-16-20-39(69)55(87)61-31-45(76)63-35(25-46(77)78)51(83)60-30-44(75)64-37(27-48(81)82)53(85)67-43(74)28-42(73)66-50(34(5)71)56(88)68-49/h15,22,32-40,49-50,71H,6-14,16-21,23-31H2,1-5H3,(H,59,86)(H,60,83)(H,61,87)(H,62,72)(H,63,76)(H,64,75)(H,65,84)(H,66,73)(H,68,88)(H,77,78)(H,79,80)(H,81,82)(H,67,74,85)/b22-15+/t33-,34-,35+,36+,37+,38+,39+,40+,49+,50+/m1/s1
External links:
PubChem link: https://pubchem.ncbi.nlm.nih.gov/compound/139589219
Citations:
  • https://pubs.acs.org/doi/10.1021/np068056f
  • Patent: WO2004062601A2

    AntibioticDB is supported by GARDP.

    If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

    The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.